Capecitabine with Weekly Paclitaxel for Advanced Breast Cancer: A Phase I Dose-Finding Trial
Catrina Uhlmann(Kantonsspital Aarau), Stefan Aebi(University of Lucerne), Walter Mingrone(Kantonsschule Olten), Natalie Rijken(Swiss Group For Clinical Cancer Research), Christoph Rochlitz, Peter Brauchli(University of St.Gallen), Daniel Rauch(Washington University in St. Louis), Bernhard C. Pestalozzi(University of Zurich), Pierluigi Ballabeni(Swiss Group For Clinical Cancer Research)
Cited by 16
Related Papers
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial
|The Lancet|2009|665
Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program
|Annals of Oncology|2017|396
Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial
|The Lancet|2015|392